Trials / Completed
CompletedNCT07260084
Prognostic Impact of Frailty in Cardiogenic Shock
Prognostic Impact of Frailty in Cardiogenic Shock: Nationwide Cohort Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 207,419 (actual)
- Sponsor
- Samsung Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this observational study is to show prognostic impact of frailty in cardiogenic shock according to age. The main questions it aims to answer are: * Can frailty successfully predict outcomes in cardiogenic shock? * Whether the impact of frailty would differ with age in cardiogenic shock?
Conditions
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2023-10-31
- Completion
- 2023-10-31
- First posted
- 2025-12-03
- Last updated
- 2025-12-03
Source: ClinicalTrials.gov record NCT07260084. Inclusion in this directory is not an endorsement.